ArticleJournal of Ayurveda and integrative medicine
Ayurvedic evaluation and treatment of Covid 19: A case report.
Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 8 citations in OpenAlex.
- Status of evidence on efficacy and safety of Indian traditional medicine (Ayush) for COVID-19: a qualitative review and evidence map synthesis.Systematic reviews · 2026Review
- Uncovering the Role of Indian Medicinal Botanicals in COVID-19 Prevention and Management: A Review.Cureus · 2024Review
- Policy responses to COVID-19 in Sri Lanka and the consideration of Indigenous Peoples.Environmental science & policy · 2023Article
- When is industry 'sustainable'? The economics of institutional variety in a pandemic.Review of evolutionary political economy · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 patients, with underlying comorbidities are observed to develop complications. Studies have shown that hypertension (one of the comorbidities) is a risk factor for patients with severe COVID-19. There have been more patients with hypertension among those who succumbed to COVID-19 compared to the survivors. There is no proven treatment of COVID-19 as of now. Ministry of AYUSH, Government of India, has permitted use of traditional systems of medicine for treating mild to moderate cases of COVID-19. In line with this, there are few case reports which reported promising results for treatment of COVID-19 with Ayurveda. These treatment reports highlighted subdued COVID-19 infections without developing serious complications. The present case is of a young hypertensive female patient who was diagnosed with COVID-19. Ayurvedic assessment for this was Kaphavataj jwara. The patient sought Ayurvedic treatment. She was advised the treatment module including medicines, diet and behavioral interventions. Though patient was having comorbid hypertension with major COVID-19 symptoms, she recovered with exclusive Ayurvedic treatment both physically as well as psychologically with no post COVID-19 complications till date. Ayurvedic treatment module appears to be safe and efficacious with early recovery and better outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.